Cargando…

Abrogated cryptic activation of lentiviral transfer vectors

Despite significant improvements in lentivirus (LV) vector-based gene therapy there are still several safety risks using LV vectors including the potential formation of replication-competent LV particles. To address this shortcoming, we constructed a novel and safer gene transfer system using modifi...

Descripción completa

Detalles Bibliográficos
Autores principales: Luche, Ralf M., Enssle, Joerg, Kiem, Hans-Peter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3365281/
https://www.ncbi.nlm.nih.gov/pubmed/22666541
http://dx.doi.org/10.1038/srep00438
_version_ 1782234661845467136
author Luche, Ralf M.
Enssle, Joerg
Kiem, Hans-Peter
author_facet Luche, Ralf M.
Enssle, Joerg
Kiem, Hans-Peter
author_sort Luche, Ralf M.
collection PubMed
description Despite significant improvements in lentivirus (LV) vector-based gene therapy there are still several safety risks using LV vectors including the potential formation of replication-competent LV particles. To address this shortcoming, we constructed a novel and safer gene transfer system using modified SIN-based LV gene transfer vectors. Central to our approach is a conditional deletion of the Ψ packaging signal after integration in the target genome. Here we demonstrate that after transduction of target cells, conventional SIN-based LV transfer vectors can still be mobilized. However mobilization is rendered undetectable if transductions are followed by a Cre/loxP-mediated excision of Ψ. Thus conditional elimination of the packaging signal may represent another advance in increasing the safety of LV vectors for gene therapeutic treatment of chronic diseases.
format Online
Article
Text
id pubmed-3365281
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-33652812012-06-04 Abrogated cryptic activation of lentiviral transfer vectors Luche, Ralf M. Enssle, Joerg Kiem, Hans-Peter Sci Rep Article Despite significant improvements in lentivirus (LV) vector-based gene therapy there are still several safety risks using LV vectors including the potential formation of replication-competent LV particles. To address this shortcoming, we constructed a novel and safer gene transfer system using modified SIN-based LV gene transfer vectors. Central to our approach is a conditional deletion of the Ψ packaging signal after integration in the target genome. Here we demonstrate that after transduction of target cells, conventional SIN-based LV transfer vectors can still be mobilized. However mobilization is rendered undetectable if transductions are followed by a Cre/loxP-mediated excision of Ψ. Thus conditional elimination of the packaging signal may represent another advance in increasing the safety of LV vectors for gene therapeutic treatment of chronic diseases. Nature Publishing Group 2012-06-01 /pmc/articles/PMC3365281/ /pubmed/22666541 http://dx.doi.org/10.1038/srep00438 Text en Copyright © 2012, Macmillan Publishers Limited. All rights reserved http://creativecommons.org/licenses/by-nc-nd/3.0/ This work is licensed under a Creative Commons Attribution-NonCommercial-No Derivative Works 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/
spellingShingle Article
Luche, Ralf M.
Enssle, Joerg
Kiem, Hans-Peter
Abrogated cryptic activation of lentiviral transfer vectors
title Abrogated cryptic activation of lentiviral transfer vectors
title_full Abrogated cryptic activation of lentiviral transfer vectors
title_fullStr Abrogated cryptic activation of lentiviral transfer vectors
title_full_unstemmed Abrogated cryptic activation of lentiviral transfer vectors
title_short Abrogated cryptic activation of lentiviral transfer vectors
title_sort abrogated cryptic activation of lentiviral transfer vectors
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3365281/
https://www.ncbi.nlm.nih.gov/pubmed/22666541
http://dx.doi.org/10.1038/srep00438
work_keys_str_mv AT lucheralfm abrogatedcrypticactivationoflentiviraltransfervectors
AT ensslejoerg abrogatedcrypticactivationoflentiviraltransfervectors
AT kiemhanspeter abrogatedcrypticactivationoflentiviraltransfervectors